DermWire | Newest Articles http://practicaldermatology.com/dermwire/ Newest Articles en-us Fri, 24 Nov 2017 21:05:07 GMT Fri, 24 Nov 2017 21:05:07 GMT DermWire New Analysis Provides Reassurance on Biosimilar Safety http://practicaldermatology.com/dermwire/view.asp?url=new-analysis-provides-reassurance-on-biosimilar-safety And they’re … safe. Biosimilars, which have been available in the European Union since 2006, show no substantial differences in the reporting of safety information than their originators, according to a new analysis in the British Journal of Clinical Pharmacology. The analysis included 19 biosimilars and six originators. Overall, 55 general safety concerns (12 low, 21 medium, and 22 highly clinically relevant) were identified. For all substances, except for infliximab, no or o… Wed, 22 Nov 2017 04:00:00 GMT Milestone Scientific Set To Launch New Botox Delivery Instrument http://practicaldermatology.com/dermwire/view.asp?url=milestone-scientific-set-to-launch-new-botox-delivery-instrument Botulinum toxin injections may be about to get smarter and more comfortable as Milestone Scientific Inc. gears up to launch its novel and proprietary cosmetic injection instrument. The new cosmetic injection instrument allows the clinician to inject accurate doses with the precision of a stylus pen that is designed for comfort and superior tactile feel. Each injection is verified with audible sound feedback confirming unit dose and each injection is documented with an electronic record. Th… Mon, 20 Nov 2017 04:00:00 GMT Amgen Launches The Enbrel Mini Single-Dose Prefilled Cartridge With AutoTouch Reusable Autoinjector http://practicaldermatology.com/dermwire/view.asp?url=amgen-launches-the-enbrel-mini-single-dose-prefilled-cartridge-with-autotouch-reusable-autoinjector Amgen's Enbrel Mini with AutoTouch is now available in the United States. Awarded the Arthritis Foundation Ease of Use Commendation, this new and innovative delivery system provides an additional administration option for appropriate Enbrel patients. The AutoTouch reusable autoinjector has an ergonomic design that includes features that were designed with patients in mind, including an ergonomic handle, a needle designed to stay hidden during the injection, a sensor to detect placement on… Fri, 17 Nov 2017 04:00:00 GMT Water Baths As Effective As Bleach Baths for Eczema http://practicaldermatology.com/dermwire/view.asp?url=water-baths-as-effective-as-bleach-baths-for-eczema Water baths are as good as bleach baths for treating eczema, and they are safer, finds a new Northwestern Medicine study. Bleach baths can cause stinging and burning of skin, and occasionally even trigger asthma flare-ups in patients. “I don’t know if it throws the baby out with the bathwater, but bleach baths lack the evidence to support how commonly they are being recommended,” says senior author Dr. Jonathan Silverberg, an assistant professor of dermatology at Northwes… Thu, 16 Nov 2017 04:00:00 GMT Parent-supplied Photos May Allow Pediatric Derms to Make Virtual Diagnoses http://practicaldermatology.com/dermwire/view.asp?url=parent-supplied-photos-may-allow-pediatric-derms-to-make-virtual-diagnoses Parent-supplied photos taken via smartphone cameras can allow pediatric dermatologists to make a diagnosis without an office visit in many cases, new research shows. This finding, which appear in JAMA Dermatology, suggest that direct-to-patient dermatology can accurately provide pediatric dermatology care. “Advances in smartphone photography, both in quality and image transmission, may improve access to care via direct parent-to-provider telemedicine,” said Patrick McMahon, M… Thu, 16 Nov 2017 04:00:00 GMT Research: Adequate Sleep May Speed Wound Healing http://practicaldermatology.com/dermwire/view.asp?url=research-adequate-sleep-may-speed-wound-healing Getting more sleep may help wound healing, and a nutrition supplement can also add some benefit, according to a new study in the Journal of Applied Physiology. Physical and emotional stress and poor nutrition have been found to weaken the immune system. Previous studies suggest that boosting nutrients such as vitamin C, omega-3 and other amino acids reduces inflammation and speeds post-surgical healing. Researchers examined healing time (skin barrier restoration) and immune response in thr… Wed, 15 Nov 2017 04:00:00 GMT Psoriasis Severity Linked to Diabetes Risk http://practicaldermatology.com/dermwire/view.asp?url=psoriasis-severity-linked-to-diabetes-risk Psoriasis patients are more likely to develop Type 2 diabetes than their psoriasis-free counterparts, and this risk increases dramatically based on the severity of the disease, according to researchers from the Perelman School of Medicine at the University of Pennsylvania. Specifically, people with psoriasis that covers 10 percent of their body or more are 64 percent more likely to develop diabetes than those without psoriasis, independent of traditional risk factors such as body weight. Appl… Wed, 15 Nov 2017 04:00:00 GMT Sonoma Pharmaceuticals Launches Loyon http://practicaldermatology.com/dermwire/view.asp?url=sonoma-pharmaceuticals-launches-loyon Sonoma Pharmaceuticals, Inc. has begun US commercialization of the company’s new Loyon® product. Under the supervision of a healthcare practitioner, Loyon is intended to manage and relieve the scaling, erythema, and itching associated with various types of dermatoses including seborrhea and seborrheic dermatitis. Loyon is a unique, patented combination of the dry emollient Cetiol® CC and the medical silicone oil dimethicone. The liquid compound is easily applied, absorbs quickl… Wed, 15 Nov 2017 04:00:00 GMT Ortho Dermatologics Announces Aspire Higher Scholarship Honorees http://practicaldermatology.com/dermwire/view.asp?url=ortho-dermatologics-announces-aspire-higher-scholarship-honorees Ortho Dermatologics announced the nine recipients of the Aspire Higher Scholarship program, which honors the achievements of applicants or current attendees of an accredited, nonprofit, two- or four-year college, university, or advanced (post-high school) vocational or technical school who have been treated for a dermatologic condition. The nine honorees were chosen from a pool of 2,179 applicants and will each receive $10,000 toward their education. “Ortho Dermatologics is proud to… Tue, 14 Nov 2017 04:00:00 GMT Obagi Eyes the Future Under New Ownership http://practicaldermatology.com/dermwire/view.asp?url=obagi-eyes-the-future-under-new-ownership The sale of Obagi Medical Products to the Haitong International Zhonghua Finance Acquisition Fund I, L.P. and limited partners China Regenerative Medicine International (CRMI) Ltd. is now complete. The new Obagi organization will remain headquartered in Southern California. In a letter to customers announcing the sale, Jaime Castle President and General Manager, Obagi, said that under new ownership, “Obagi will renew its mission as a leading global physician-dispensed skin care company … Tue, 14 Nov 2017 04:00:00 GMT Promius Pharma Employees Fundraise for Hurricane Victims http://practicaldermatology.com/dermwire/view.asp?url=promius-pharma-employees-fundraise-for-hurricane-victims Promius Pharma LLC's employees raised $12,715 to support American Red Cross relief efforts to assist those affected by the recent hurricanes. Additionally, Promius' parent company Dr. Reddy's Laboratories matched this donation for a combined contribution of $25,215. Promius sales and marketing teams took a creative approach to fundraising by competing against one another in a "fidget spinner challenge." Participants submitted videos of themselves using the gadget, often … Tue, 14 Nov 2017 04:00:00 GMT Calling all Innovators: J J Launches Digital Beauty QuickFire Challenge http://practicaldermatology.com/dermwire/view.asp?url=calling-all-innovators--j--j-launches-digital-beauty-quickfire-challenge Johnson & Johnson Innovation LLC, in collaboration with Johnson & Johnson Consumer Inc., is launching the Digital Beauty QuickFire Challenge. The challenge will encourage start-up companies to create the most novel, future-forward digital beauty solutions in an effort to provide better skincare outcomes for consumers around the world. The winner(s) of the challenge will receive up to a total of $50,000 in funding to help advance their product prototype toward commercialization. In add… Mon, 13 Nov 2017 04:00:00 GMT ADAM Now Accepting Nominations for 2018 Practice Manager of the Year Award http://practicaldermatology.com/dermwire/view.asp?url=adam-now-accepting-nominations-for-2018-practice-manager-of-the-year-award The Association of Dermatology Administrators and Managers (ADAM) is now accepting nominations for its annual Practice Manager of the Year Award, made possible in collaboration with CareCredit. Now in its fifth year, the Practice Manager of the Year Award identifies and rewards excellence among practice managers, and recognizes the office professional who best demonstrates innovative thinking, insight and leadership within their practice and community from across North America. Winners are s… Mon, 13 Nov 2017 04:00:00 GMT Isdin Introduces Two New Products http://practicaldermatology.com/dermwire/view.asp?url=isdin-introduces-two-new-products ISDIN is rolling out ISDIN Age Contour plus a new shade in their ISDINCEUTICS Skin Drops collection. ISDIN AGE CONTOUR is a triple-action face and neck cream that aims to reduce jawline sagging and glycation in the skin as well as protect against pollution. And the latest shade in ISDINCEUTICS Skin Drops collection is CARAMEL. Existing shades include Sand and Bronze. Shades can be used separately or combined to find the perfect match for an individual’s skin tone. This light-weight,… Thu, 9 Nov 2017 04:00:00 GMT Possible Eczema Breakthrough? S. aureus May Promote Skin Inflammation via IL-36-Mediated T Cell Responses http://practicaldermatology.com/dermwire/view.asp?url=possible-eczema-breakthrough--s-aureus-may-promotes-skin-inflammation-via-il-36-mediated-t-cell-responses Toxin-producing bacteria on the surface of our skin may induce a protein that causes our own cells to react and cause inflammation, according to research published online in Cell Host & Microbe. “Our skin is covered with bacteria as part of our normal skin microbiome and typically serves as a barrier that protects us from infection and inflammation. However, when that barrier is broken, the increased exposure to certain bacteria really causes problems,” says Lloyd Miller, M.D.… Wed, 8 Nov 2017 04:00:00 GMT NRS Introduces New Standard Classification and Pathophysiology of Rosacea http://practicaldermatology.com/dermwire/view.asp?url=nrs-introduces-new-standard-classification-and-pathophysiology-of-rosacea The National Rosacea Society (NRS) is introducing a new standard classification and pathophysiology of rosacea. The updated system appears in the Journal of the American Academy of Dermatology. Developed by a consensus committee and review panel of 28 rosacea experts worldwide, the updated system is based on the substantial advances in the understanding of rosacea gained through scientific investigations over the last 15 years. While the original classification system designated the mos… Wed, 8 Nov 2017 04:00:00 GMT Long-Term Use of Lilly's Taltz Shows Efficacy Improvements in PsA for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors http://practicaldermatology.com/dermwire/view.asp?url=long-term-use-of-lillys-taltz-shows-efficacy-improvements-in-psa-for-patients-with-prior-inadequate-response-or-intolerance-to-tnf-inhibitors Patients with active psoriatic arthritis (PsA) treated with Taltz (ixekizumab), who were previously intolerant or had inadequate responses to TNF inhibitors, showed improvements in the signs and symptoms of PsA across treatment groups for up to 52 weeks, according to Eli Lilly and Company. Interim results from the extension period of the Phase 3 SPIRIT-P2 study are being presented in an oral presentation at the American College of Rheumatology (ACR)/Association of Rheumatology Health Profession… Wed, 8 Nov 2017 04:00:00 GMT Novan Plans to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution http://practicaldermatology.com/dermwire/view.asp?url=novan-plans-to-complete-development-of-sb204-acne-candidate-via-third-party-funding-and-execution Novan, Inc., has agreed in principle to a business structure that would enable further development and advancement of SB204 for the treatment of acne vulgaris via third party financing and third party execution of one additional Phase 3 pivotal trial that is required before the filing of a New Drug Application (NDA). The proposed Phase 3 trial would be executed by the third party’s dermatology drug development team, which plans to utilize a clinical research organization with extensive … Wed, 8 Nov 2017 04:00:00 GMT DermTech Adds Dr. Harold Rabinovitz to Scientific Advisory Board http://practicaldermatology.com/dermwire/view.asp?url=dermtech-adds-harold-rabinovitz-to-scientific-advisory-board DermTech, Inc., appointed Harold Rabinovitz, MD to its Scientific Advisory Board. Dr. Rabinovitz is a Board Certified Dermatologist and a voluntary Clinical Professor of Dermatology at University of Miami School of Medicine. He is world-renown for his work in dermoscopy and confocal microscopy. Dr. Rabinovitz's research interests focus on identification of tumor characteristics with new research instruments and education on early tumor detection. "Melanoma is the great masquerader… Wed, 8 Nov 2017 04:00:00 GMT Save the Dates: eRelevance Launches National Marketing Education Tour for Aesthetic Healthcare Practices http://practicaldermatology.com/dermwire/view.asp?url=erelevance-launches-national-marketing-education-tour-for-aesthetic-healthcare-practices eRelevance Corporation announced the expansion of its popular marketing education workshops to more cities nationwide. The workshops help aesthetic healthcare providers understand the significant opportunity in marketing to their existing patients to generate more repeat business to support their business goals. Through an intimate and valuable peer-to-peer networking format, the workshops address the internal marketing challenges faced by aesthetic healthcare practices. They feature indus… Tue, 7 Nov 2017 04:00:00 GMT New from Jergens: Nourishing Honey Dry Skin Moisturizer http://practicaldermatology.com/dermwire/view.asp?url=new-from-jergens-nourishing-honey-dry-skin-moisturizer Jergens is launching their new Nourishing Honey Dry Skin Moisturizer. Formulated with antioxidant-packed Orange Blossom Honey, which is known to contain potent antibacterial and anti-inflammatory properties, the new Jergens® Nourishing Honey Dry Skin Moisturizer softens dry skin and keeps it smooth and hydrated 24/7. Other features include citrusy Orange Blossom scent and a non-sticky formula. A 16.8-oz bottle retails for $5.99. Mon, 6 Nov 2017 04:00:00 GMT Sensus Healthcare Launches SRT-100 for Keloid Prevention and Treatment in China http://practicaldermatology.com/dermwire/view.asp?url=sensus-healthcare-launches-srt-100-in-china-for-keloid-prevention-and-treatment Sensus Healthcare, Inc. launched the SRT-100™ in China for the treatment and prevention of keloids with Chindex Medical Limited. Sensus also announced the extension of its exclusive distribution agreement with Chindex Medical, a joint venture between Fosun Pharma and Chindex International, Inc., through 2020. SRT-100 launch activities were organized by Chindex Medical in conjunction with the International Congress of Dermatologic & Aesthetic Surgery International League (DASIL) i… Fri, 3 Nov 2017 04:00:00 GMT Gut Microbiome May Affect How Metastatic Melanoma Responds to Immunotherapy http://practicaldermatology.com/dermwire/view.asp?url=gut-microbiome-may-affect-how-metastatic-melanoma-responds-to-immunotherapy The gut microbiome can influence how metastatic melanoma responds to immunotherapy, researchers from The University of Texas MD Anderson Cancer Center report in the journal Science. Patients with metastatic melanoma treated with anti-PD1 checkpoint blockade have their disease controlled longer if they have a more diverse population of bacteria in the gut or an abundance of certain types of bacteria, according to the team’s analysis of fecal samples to assess patients’ gut microbio… Fri, 3 Nov 2017 04:00:00 GMT Study: PsO, RA Patients Prescribed Similar Drugs, But PsO Patients Face Higher Liver Disease Risk http://practicaldermatology.com/dermwire/view.asp?url=study-pso-ra-patients-prescribed-similar-drugs-yet-pso-patients-face-higher-liver-disease-risk Compared to controls, patients with psoriasis (PsO) are at higher risk for serious liver disease than patients with rheumatoid arthritis, reports a in the Journal of Investigative Dermatology from researchers at the Perelman School of Medicine at the University of Pennsylvania. The study is the first population-based study to simultaneously address the risk for liver disease in patients with these inflammatory diseases and psoriatic arthritis (PsA), in a large population of more than 197,000 … Fri, 3 Nov 2017 04:00:00 GMT FDA Accepts Ortho Dermatologic’s NDA for Novel Plaque Psoriasis Treatment, IDP-118 http://practicaldermatology.com/dermwire/view.asp?url=fda-accepts-ortho-dermatologics-nda-for-novel-plaque-psoriasis-treatment-idp-118 The US Food and Drug Administration has accepted Ortho Dermatologic's New Drug Application (NDA) for IDP-118 (halobetasol propionate and tazarotene) lotion, an investigational topical treatment for plaque psoriasis. The PDUFA action date is June 18, 2018. If approved, IDP-118 will be the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation for the treatment of plaque psoriasis in adult patients, allowing for a potenti… Thu, 2 Nov 2017 04:00:00 GMT